Michael P Coleman Selected Research

nicotinamidenucleotide amidase

3/2017

NMN Deamidase Delays Wallerian Degeneration and Rescues Axonal Defects Caused by NMNAT2 Deficiency In Vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael P Coleman Research Topics

Disease

24	Wallerian Degeneration 02/2022 - 02/2002
7	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 11/2021 - 03/2003
6	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 04/2007
5	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2021 - 12/2003
4	Peripheral Nervous System Diseases (PNS Diseases) 10/2021 - 01/2012
4	Frontotemporal Dementia (Semantic Dementia) 01/2021 - 08/2011
3	Parkinson Disease (Parkinson's Disease) 01/2021 - 04/2007
2	Polyneuropathies (Polyneuropathy) 10/2021 - 10/2019
2	Charcot-Marie-Tooth Disease (Peroneal Muscular Atrophy) 01/2021 - 04/2011
2	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2020 - 12/2018
2	Inflammation (Inflammations) 05/2019 - 01/2016
2	Tauopathies 03/2016 - 03/2012
2	Neoplasms (Cancer) 01/2016 - 12/2004
2	Glaucoma 09/2008 - 04/2007
1	Zika Virus Infection 01/2022
1	Diabetic Neuropathies (Diabetic Neuropathy) 10/2021
1	Hereditary Spastic Paraplegia 01/2021
1	type 1 Pena Shokeir syndrome 10/2019
1	Erythromelalgia (Erythermalgia) 10/2019
1	Neuroinflammatory Diseases 05/2019
1	Infections 01/2019
1	Cognitive Dysfunction 01/2018
1	Ganglion Cysts (Ganglion) 11/2016
1	Hyperglycemia 08/2015
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 08/2015
1	Hypoglycemia (Reactive Hypoglycemia) 08/2015
1	Huntington Disease (Huntington's Disease) 08/2011
1	Peripheral Nerve Injuries 04/2011
1	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 04/2007
1	Wounds and Injuries (Trauma) 02/2006
1	Retrograde Degeneration 12/2003

Drug/Important Bio-Agent (IBA)

19	Proteins (Proteins, Gene)FDA Link 01/2020 - 03/2004
8	NAD (NADH)IBA 02/2022 - 01/2012
5	EnzymesIBA 01/2020 - 04/2011
3	Pharmaceutical PreparationsIBA 01/2020 - 12/2004
2	NAD+ Nucleosidase (NAD(P) Nucleosidase)IBA 01/2022 - 11/2021
2	Biological ProductsIBA 10/2021 - 10/2021
2	ParvalbuminsIBA 01/2021 - 01/2018
2	Nicotinamide-Nucleotide AdenylyltransferaseIBA 10/2019 - 04/2003
2	Amyloid (Amyloid Fibrils)IBA 01/2018 - 04/2007
2	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 03/2016 - 03/2012
2	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2013 - 12/2003
2	Protein Isoforms (Isoforms)IBA 01/2010 - 03/2003
1	Glycoside Hydrolases (Endoglycosidases)IBA 02/2022
1	TubulinIBA 01/2022
1	tau Proteins (tau Protein)IBA 12/2021
1	Carisoprodol (Soma)FDA LinkGeneric 01/2021
1	Amyloid beta-PeptidesIBA 01/2020
1	Interleukin-1beta (Interleukin 1 beta)IBA 05/2019
1	LipopolysaccharidesIBA 05/2019
1	Leucine (L-Leucine)FDA Link 01/2019
1	NucleotidesIBA 01/2019
1	P7C3-A20IBA 12/2018
1	DNA-Binding Proteins (DNA Binding Protein)IBA 01/2018
1	nicotinamidenucleotide amidaseIBA 03/2017
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 11/2016
1	Nicotinamide PhosphoribosyltransferaseIBA 01/2016
1	Glucagon (Glukagon)FDA Link 08/2015
1	Insulin (Novolin)FDA Link 08/2015
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 08/2015
1	Adenosine Triphosphate (ATP)IBA 04/2015
1	BIX 02189IBA 01/2013
1	U 0126 (UO 126)IBA 01/2013
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2013
1	2- (2- chloro- 4- iodophenylamino)- N- cyclopropylmethoxy- 3,4- difluorobenzamideIBA 01/2013
1	IsoenzymesIBA 01/2012
1	Myelin ProteinsIBA 04/2011
1	Niacinamide (Nicotinamide)FDA LinkGeneric 04/2011
1	polyglutamineIBA 04/2007
1	Apolipoprotein E4IBA 04/2007
1	Nuclear Proteins (Protein, Nuclear)IBA 03/2006
1	Nicotinamide MononucleotideIBA 02/2006
1	glutamine-synthetase adenylyltransferaseIBA 02/2006
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2005
1	ProdrugsIBA 12/2004
1	CilengitideIBA 12/2004
1	Peptides (Polypeptides)IBA 12/2004
1	N-acetyltalosaminuronic acid (NAT)IBA 03/2004
1	HydrolasesIBA 12/2003
1	UbiquitinIBA 12/2003
1	Annexin A5IBA 06/2003
1	Messenger RNA (mRNA)IBA 03/2003

Therapy/Procedure

5	Axotomy 10/2006 - 02/2002
2	Drug Therapy (Chemotherapy) 10/2021 - 01/2020
1	Therapeutics 02/2006